Categories AlphaGraphs, Earnings, Health Care
AMGN Earnings: Highlights of Amgen’s Q3 2023 financial results
Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023. The company also provided guidance for fiscal 2023.
Adjusted earnings increased to $4.96 per share in the September quarter from $4.70 per share in the year-ago period. The reported net income was $1.73 billion or $3.22 per share in the latest quarter, compared to $2.14 billion or $3.98 per share in the same period of last year.
Total revenues increased 4% from last year to $6.9 billion during the three-month period. There was a 5% growth in product sales, benefiting from double-digit volume growth.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025
For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model
Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third
Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance
Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved the goal of $4 bln
